TNFAIP3 and acute lymphoblastic leukemia: Our results clearly demonstrated that TNFAIP3 mutation is positively correlated with the high‐risk stratification and ETP‐ALL, suggesting that TNFAIP3 mutation might be associated with adverse clinical outcomes in T‐ALL patients.